Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piflufolastat (18F) vs Flotufolastat (18F) PET in Prostate Cancer BCR
NCT06604442Phase 4Completed
- Sponsor
- Blue Earth Diagnostics
- Start
- Dec 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of piflufolastat f 18, flotufolastat f 18 in prostate cancer (PCa), sponsored by Blue Earth Diagnostics. Started Dec 2024; status: completed.
02
Drugs
piflufolastat f 18flotufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06604442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06604442.